Ferabright (ferumoxytol injection)
MRI of the brain in adults with known or suspected malignant neoplasms
Key Facts
About Azurity Pharmaceuticals
Azurity Pharmaceuticals is a US-based, private specialty pharma company founded in 2014, targeting overlooked patient needs with a portfolio of over 50 approved products. It leverages a 'Next-Gen Commercial Model' utilizing data, analytics, and AI-driven digital tools to enhance commercial reach and stakeholder engagement. The company has a significant global footprint and recently launched new proprietary products like Ferabright and ARYNTA, signaling a strategic shift beyond pure generics into branded specialty pharmaceuticals.
View full company profileAbout NextSource Pharma
Azurity Pharmaceuticals is a US-based, private specialty pharma company founded in 2018, with a core mission of serving overlooked patients through customized drug formulations. It has built a commercial-stage portfolio of over 50 products, spanning key therapeutic areas, and utilizes a Next-Gen Commercial Model powered by data, analytics, and AI-driven tools. The company has a global footprint in over 50 countries and recently launched new products like Ferabright and Arynta, demonstrating ongoing pipeline execution and commercial growth.
View full company profile